Phase Ib study of PGG beta glucan in combination with anti-MUC1 antibody (BTH1704) and gemcitabine for the treatment of advanced pancreatic cancer. Background: In human cancers, loss of PTEN, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results